CGAS and neoplasm: Given that tumor cells frequently undergo necrosis, DNA damage and nuclear rupture—all of which would expose the cytoplasm to an abundance of genomic DNA—the question remains: why are tumor cells not critically inhibited and destroyed by cGAS-STING-mediated immunosurveillance?